Evidence map›Paper›PMID 27081082›Full record

ArticleOncotarget2016

s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells.

Guillaume Brocqueville, Renee S Chmelar, Hélène Bauderlique-Le Roy, Emeric Deruy, Lu Tian, Robert L Vessella, Norman M Greenberg, Larry R Rohrschneider, Roland P Bourette

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Guillaume BrocquevilleUniversity of Lille, CNRS, Institut Pasteur de Lille, UMR 8161-M3T-Mechanisms of Tumorigenesis and Targeted Therapies, SIRIC ONCOLille, F-59000 Lille, France.
Renee S ChmelarDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Hélène Bauderlique-Le RoyUniversity of Lille, CNRS, Institut Pasteur de Lille, UMR 8161-M3T-Mechanisms of Tumorigenesis and Targeted Therapies, SIRIC ONCOLille, F-59000 Lille, France.
Emeric DeruyBioImaging Center Lille, Institut Pasteur de Lille, University of Lille, F-59000 Lille, France.
Lu TianUniversity of Lille, CNRS, Institut Pasteur de Lille, UMR 8161-M3T-Mechanisms of Tumorigenesis and Targeted Therapies, SIRIC ONCOLille, F-59000 Lille, France.
Robert L VessellaDepartment of Urology, University of Washington, Seattle, WA 98195, USA.
Norman M GreenbergDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Larry R RohrschneiderDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Roland P BouretteUniversity of Lille, CNRS, Institut Pasteur de Lille, UMR 8161-M3T-Mechanisms of Tumorigenesis and Targeted Therapies, SIRIC ONCOLille, F-59000 Lille, France.
Fred Hutch Cancer Center · USCentre National de la Recherche Scientifique · FROnco Lille · FRInstitut Pasteur de Lille · FRUniversity of Washington · US

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETER S NELSON · 2002 to 2026
$58.1M
Transmembrane Proteases and Prostate CarcinogenesisP01CA085859 · NCI · UNIVERSITY OF WASHINGTON · PI VESSELLA, ROBERT LOUIS · 2002 to 2013
$21.2M
TUMOR CELL BIOLOGY OF THE FMS ONCOGENE PROTEINSR01CA040987 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROHRSCHNEIDER, LARRY RAY · 1985 to 2005
$2.2M
The role of s-SHIP in normal and tumorigenic development of the skinR56CA123360 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROHRSCHNEIDER, LARRY RAY · 2006 to 2007
$507k
NCI NIH HHS P01 CA085859NCI NIH HHS P50 CA097186NCI NIH HHS R01 CA040987NCI NIH HHS R56 CA123360
6 · The paper itself

Abstract

Isolation of prostate stem cells (PSCs) is crucial for understanding their biology during normal development and tumorigenesis. In this aim, we used a transgenic mouse model expressing GFP from the stem cell-specific s-SHIP promoter to mark putative stem cells during postnatal prostate development. Here we show that cells identified by GFP expression are present transiently during early prostate development and localize to the basal cell layer of the epithelium. These prostate GFP+ cells are a subpopulation of the Lin- CD24+ Sca-1+ CD49f+ cells and are capable of self-renewal together with enhanced growth potential in sphere-forming assay in vitro, a phenotype consistent with that of a PSC population. Transplantation assays of prostate GFP+ cells demonstrate reconstitution of prostate ducts containing both basal and luminal cells in renal grafts. Altogether, these results demonstrate that s-SHIP promoter expression is a new marker for neonatal basal prostate cells exhibiting stem cell properties that enables PSCs in situ identification and isolation via a single consistent parameter. Transcriptional profiling of these GFP+ neonatal stem cells showed an increased expression of several components of the Wnt signaling pathway. It also identified stem cell regulators with potential applications for further analyses of normal and cancer stem cells.

Indexed as

AnimalsBiomarkersEpithelial CellsMaleMiceMice, SCIDMice, TransgenicPhosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesProstateRatsRats, Sprague-DawleyStem CellsBiomarkersPhosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatasesepithelial cellsprostates-SHIPstem cellstransgenic mouse

Identifiers

PMID27081082
PMCPMC5045392
OpenAlexW2336108706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.